Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Specialty Drug Distribution Market Outlook 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Specialty Drug Distribution Market is experiencing rapid growth, with an estimated value of USD 2.34 billion in 2023 and a projected Compound Annual Growth Rate (CAGR) of 14.20%. The market is expected to reach USD 5.95 billion by 2030, driven by the rising demand for drugs used in the treatment of serious or life-threatening disorders such as Hepatitis, Cancer, and Multiple Sclerosis. However, certain challenges and restraints such as steep drug prices and changing regulatory frameworks need to be addressed.
Market Dynamics
- Drivers: The market is propelled by the increasing prevalence of complex chronic conditions and the need for extensive reach and fast shipping services to meet the demand for specialty drugs. Additionally, government support for drug development further contributes to market growth.
- Restraints: The market faces challenges due to the high prices of specialty drugs, limiting patient access. Limited reimbursement options also hinder market growth.
- Opportunities: The implementation of patient assistance programs can help patients afford their treatments, opening new opportunities for market expansion. Moreover, the adoption of cold chain management for temperature monitoring and sophisticated environmental systems can enhance drug distribution capabilities.
- Challenges: The market encounters challenges related to the evolving regulatory landscape, necessitating adaptability and compliance by industry stakeholders.
Segmentation and Coverage
The research report categorizes the Global Specialty Drug Distribution Market to forecast revenues and analyze trends in the following sub-markets:
- Indication: The market is studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis. Hemophilia is projected to witness significant market share during the forecast period.
- Type: The market is studied across Full-line Wholesalers and Specialty Distributors. Specialty Distributors are expected to witness significant market share during the forecast period.
- Distribution Type: The market is studied across Clinic/ASCs, Home Health, Inpatient, Mail Delivery, Outpatient, and Retail. Inpatient distribution is projected to witness significant market share during the forecast period.
- Distribution Channel: The market is studied across Hospitals & Care Providers, Independent Pharmacies, Large Chain Pharmacies, Online Stores, and Specialty Pharmacies. Hospitals & Care Providers are projected to witness significant market share during the forecast period.
- Region: The market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. Europe, Middle East & Africa commanded the largest market share of 38.94% in 2022, followed by Americas.
Market Statistics
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. Multiple currency support aids organizational leaders in making well-informed decisions. Historical years considered are 2018 to 2021, 2022 is the base year, 2023 is the estimated year, and 2024 to 2030 are the forecast period.
FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates the Global Specialty Drug Distribution Market, offering a comprehensive evaluation of vendors based on Business Strategy and Product Satisfaction metrics. Vendors are categorized into four distinct quadrants - Forefront (F), Pathfinder (P), Niche (N), or Vital (V) - representing varying levels of success.
Market Share Analysis
The Market Share Analysis provides valuable insights into the current state of vendors in the market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, companies gain a better understanding of their performance and market competitiveness.
Conclusion
The Global Specialty Drug Distribution Market is witnessing robust growth, driven by the increasing demand for drugs used in the treatment of serious diseases such as Hepatitis, Cancer, and Multiple Sclerosis. The market's expansion is supported by patient assistance programs, advancements in cold chain management, and government support for drug development. However, challenges related to drug pricing and regulatory changes require continuous adaptation by industry players. The market's future growth lies in efficiently addressing patient needs and optimizing drug distribution channels.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2023-2030 |
| Estimated Market Value (USD) in 2023 | $2.34 Billion |
| Forecasted Market Value (USD) by 2030 | $5.95 Billion |
| Compound Annual Growth Rate | 14.2% |
| Regions Covered | Global |
Key Topics Covered
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Specialty Drug Distribution Market, by Indication
7. Specialty Drug Distribution Market, by Type
8. Specialty Drug Distribution Market, by Distribution Type
9. Specialty Drug Distribution Market, by Distribution Channel
10. Americas Specialty Drug Distribution Market
11. Asia-Pacific Specialty Drug Distribution Market
12. Europe, Middle East & Africa Specialty Drug Distribution Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
Companies Mentioned
- Alliance Healthcare
- AmerisourceBergen Corporation
- Cardinal Health, Inc.
- CuraScript, Inc.
- CVS Health Corporation
- Diplomat Pharmacy, Inc.
- Express Scripts Holding Company
- McKesson Corporation
- Mediceo Paltac Holdings Co., Ltd.
- Pfizer Inc.
- Shanghai Pharma
- Sinopharm
- Smith Drug Co. Inc.
For more information about this report visit https://www.researchandmarkets.com/r/m98frv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
